The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.
 
Priyanka Sharma
Consulting or Advisory Role - Abbvie; Almac Diagnostics; AstraZeneca; TapImmune Inc.
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Cosmo Biosciences (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Almac Diagnostics; AstraZeneca; Celgene
 
Vandana Gupta Abramson
Consulting or Advisory Role - Novartis
Research Funding - Astellas Pharma; Genentech/Roche
 
Anne O'Dea
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Harsh B Pathak
No Relationships to Disclose
 
Ziyan Y. Pessetto
Honoraria - Qiagen
 
Yen Y. Wang
No Relationships to Disclose
 
Karissa Finke
No Relationships to Disclose
 
Marc Steven Hoffmann
Honoraria - Janssen Oncology
Speakers' Bureau - Janssen Oncology
 
Manana Elia
No Relationships to Disclose
 
Sharon Lewis
No Relationships to Disclose
 
Jecinta Scott
No Relationships to Disclose
 
Jilliann De Jong
No Relationships to Disclose
 
Julia Urban
Travel, Accommodations, Expenses - TapImmune Inc.
 
Jaimie Heldstab
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Stephanie LaFaver
No Relationships to Disclose
 
Stephen K. Williamson
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Oncology (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Exelis (Inst); Merck Serono (Inst); Nektar (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst); Tesaro (Inst)
 
Greg Reed
No Relationships to Disclose
 
Bruce F. Kimler
No Relationships to Disclose
 
Qamar J. Khan
Consulting or Advisory Role - Novartis; pfizer; Roche/Genentech
Research Funding - Novartis
 
Andrew K. Godwin
No Relationships to Disclose